ClinicalTrials.Veeva

Menu

A Retrospective Review of Early Onset Spinal Deformity Patients Treated With the Ellipse MAGEC System

E

Ellipse Technologies

Status

Completed

Conditions

Thoracic Insufficiency Syndrome

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine the safety profile and probable benefit of the Ellipse Technologies Inc. MAGEC System in subjects with early onset spinal deformity associated with thoracic insufficiency syndrome.

Enrollment

54 patients

Sex

All

Ages

Under 11 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Early onset spinal deformity with any etiology
  • Cobb angle measurement of 30 degrees or greater at the time of primary surgery
  • Thoracic spine height (T1 to T12) less than 22 cm at the time of primary surgery
  • Age less than 11 years old at the time of MAGEC implant
  • Implanted with the MAGEC system as either a primary or secondary revision spinal bracing procedure
  • Patient has been implanted for a minimum of 6 months
  • Patient signs informed consent for the use of their personal private data

Exclusion criteria

  • Patient declines to sign informed consent for the use of their personal private data.

Trial design

54 participants in 1 patient group

MAGEC Implant
Description:
All patients implanted with the MAGEC System will be reviewed for inclusion into this retrospective study.

Trial contacts and locations

15

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems